3 news items
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
ADPT
31 May 24
, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
ADPT
7 May 24
of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
ADPT
2 Apr 24
, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks
- Prev
- 1
- Next